These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9662328)

  • 1. p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice.
    Landesman-Bollag E; Channavajhala PL; Cardiff RD; Seldin DC
    Oncogene; 1998 Jun; 16(23):2965-74. PubMed ID: 9662328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
    Curtis DJ; Robb L; Strasser A; Begley CG
    Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss.
    Blyth K; Terry A; O'Hara M; Baxter EW; Campbell M; Stewart M; Donehower LA; Onions DE; Neil JC; Cameron ER
    Oncogene; 1995 May; 10(9):1717-23. PubMed ID: 7753548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
    Baxter EW; Blyth K; Cameron ER; Neil JC
    J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
    Elson A; Deng C; Campos-Torres J; Donehower LA; Leder P
    Oncogene; 1995 Jul; 11(1):181-90. PubMed ID: 7624126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis.
    Channavajhala P; Seldin DC
    Oncogene; 2002 Aug; 21(34):5280-8. PubMed ID: 12149649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma.
    De la Cueva E; García-Cao I; Herranz M; López P; García-Palencia P; Flores JM; Serrano M; Fernández-Piqueras J; Martín-Caballero J
    Oncogene; 2006 Jul; 25(29):4128-32. PubMed ID: 16462758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.
    Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC
    J Immunol; 1998 Nov; 161(10):5164-70. PubMed ID: 9820486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of aberrant Y chromosomes in gamma-ray-induced thymic lymphomas lacking p53.
    Chou D; Matsuki J; Saitou Y; Kosugi SI; Shinbo T; Gejyo F; Niwa O; Kominami R
    Mol Carcinog; 1999 Nov; 26(3):157-62. PubMed ID: 10559790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice.
    Ward JM; Tadesse-Heath L; Perkins SN; Chattopadhyay SK; Hursting SD; Morse HC
    Lab Invest; 1999 Jan; 79(1):3-14. PubMed ID: 9952106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic and cellular events during radiation-induced thymic lymphomagenesis in the p53 heterozygous (+/-) B10 mouse.
    Tanaka K; Watanabe K; Mori M; Kamisaku H; Tsuji H; Hirabayashi Y; Inoue T; Yoshida K; Aizawa S
    Int J Radiat Biol; 2002 Mar; 78(3):165-72. PubMed ID: 11869471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymic lymphomas in interleukin 9 transgenic mice.
    Renauld JC; van der Lugt N; Vink A; van Roon M; Godfraind C; Warnier G; Merz H; Feller A; Berns A; Van Snick J
    Oncogene; 1994 May; 9(5):1327-32. PubMed ID: 8152793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA double-strand breaks, p53, and apoptosis during lymphomagenesis in scid/scid mice.
    Gurley KE; Vo K; Kemp CJ
    Cancer Res; 1998 Jul; 58(14):3111-5. PubMed ID: 9679979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bax accelerates tumorigenesis in p53-deficient mice.
    Knudson CM; Johnson GM; Lin Y; Korsmeyer SJ
    Cancer Res; 2001 Jan; 61(2):659-65. PubMed ID: 11212265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the p53 and scid genes do not cooperate in lymphomagenesis in doubly heterozygous mice.
    Kosugi S; Miyazawa T; Chou D; Saito Y; Shinbo T; Matsuki A; Okano H; Miyaji C; Watanabe H; Hatakeyama K; Niwa O; Kominami R
    Biochem Biophys Res Commun; 1999 Feb; 255(1):99-103. PubMed ID: 10082662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for protein kinase CK2 in cell proliferation: evidence using a kinase-inactive mutant of CK2 catalytic subunit alpha.
    Lebrin F; Chambaz EM; Bianchini L
    Oncogene; 2001 Apr; 20(16):2010-22. PubMed ID: 11360185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.
    Feldman BJ; Reid TR; Cleary ML
    Oncogene; 1997 Nov; 15(22):2735-42. PubMed ID: 9401000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of illegitimate V(D)J recombination or microhomology-mediated nonhomologous end-joining in the formation of intragenic deletions of the Notch1 gene in mouse thymic lymphomas.
    Tsuji H; Ishii-Ohba H; Katsube T; Ukai H; Aizawa S; Doi M; Hioki K; Ogiu T
    Cancer Res; 2004 Dec; 64(24):8882-90. PubMed ID: 15604248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo.
    Blyth K; Vaillant F; Hanlon L; Mackay N; Bell M; Jenkins A; Neil JC; Cameron ER
    Cancer Res; 2006 Feb; 66(4):2195-201. PubMed ID: 16489021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
    Petit B; Leroy K; Kanavaros P; Boulland ML; Druet-Cabanac M; Haioun C; Bordessoule D; Gaulard P
    Hum Pathol; 2001 Feb; 32(2):196-204. PubMed ID: 11230707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.